|
APLS Apellis Pharmaceuticals Inc 1492422 |
| Balance Sheet |
|
Current Assets
|
833,897,000 |
|
Assets
|
901,866,000 |
|
Current Liabilities
|
191,260,000 |
|
Liabilities
|
664,745,000 |
|
Equity
|
237,121,000 |
|
Shares Out
|
121,766,000 |
| Cash Flow Statement |
|
Operating Cash Flow
|
-107,226,000 |
|
Investing Cash Flow
|
-383,000 |
| Market Analysis |
Market Cap
|
4,316,615,427 |
|
Price
|
29.94 |
|
BVPS
|
1.95 |
|
PB
|
15.38 |
|
EPS
|
-2.74 |
|
PS
|
5.48 |
|
FCF
|
-107,609,000 |
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view APLS documents filed with the SEC.
APLS Filings
Clear
